You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

Sharp drop following new 52-week high

Zoetis Inc is sharply lower today, dropping (U.S.)$0.91 or 1.92% to (U.S.)$46.40 after setting a new 52-week high. Over the last five days, shares have gained 2.20% and are currently 2.54% off of the 52-week high. Shares have outperformed the S&P 500 by 35.64% during the last year.

Key company metrics

Open(U.S.) $47.28

Previous close(U.S.) $47.31

High(U.S.) $47.34

Low(U.S.) $46.34

Bid / Ask(U.S.) $46.40 / (U.S.) $46.41

YTD % change+7.83%

Volume1,439,240

Average volume (10-day)3,681,316

Average volume (1-month)4,363,525

Average volume (3-month)3,729,882

52-week range(U.S.) $28.14 to (U.S.) $47.61

Beta--

Trailing P/E39.95×

P/E 1 year forward28.74×

Forward PEG2.63×

Indicated annual dividend(U.S.) $0.33

Dividend yield0.72%

Trailing EPS(U.S.) $1.16

Updated March 3 2:46 PM EST. Delayed by at least 15 minutes.

Key company metrics

Open(U.S.) $47.28

Previous close(U.S.) $47.31

High(U.S.) $47.34

Low(U.S.) $46.34

Bid / Ask(U.S.) $46.40 / (U.S.) $46.41

YTD % change+7.83%

Volume1,439,240

Average volume (10-day)3,681,316

Average volume (1-month)4,363,525

Average volume (3-month)3,729,882

52-week range(U.S.) $28.14 to (U.S.) $47.61

Beta--

Trailing P/E39.95×

P/E 1 year forward28.74×

Forward PEG2.63×

Indicated annual dividend(U.S.) $0.33

Dividend yield0.72%

Trailing EPS(U.S.) $1.16

Updated March 3 2:46 PM EST. Delayed by at least 15 minutes.

About

Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion

Continue reading

animals. The primary livestock species are cattle (both beef and dairy), swine, poultry, sheep and fish, and the primary companion animal species are dogs, cats and horses. In February 2014, Benchmark Holdings PLC purchased aquaculture vaccine and development assets from animal health company Zoetis Inc.

Headquarters

Earnings

Net income declined by 19.36%, year over year, to (U.S.)$0.25 per share during the most recently completed quarter. However, this was among the strongest results reported by any company in this industry.

Restrictions

All rights reserved. Republication or redistribution of Thomson Reuters content, including by framing or similar means, is prohibited without the prior written consent of Thomson Reuters. Thomson Reuters is not liable for any errors or delays in Thomson Reuters content, or for any actions taken in reliance on such content. ‘Thomson Reuters’ and the Thomson Reuters logo are trademarks of Thomson Reuters and its affiliated companies.